FT商學院

Predictions that weight-loss drugs will dampen appetite hard to swallow for snacks makers
抑制食慾的明星減肥藥打擊食品飲料行業

Analysts anticipate that Ozempic and Wegovy will hurt sales at some groups as patients reduce calorie intake
分析師預計,隨著患者減少卡路里攝入量,Ozempic 和 Wegovy 將損害某些集團的銷售額 。

Following predictions that a new generation of weight-loss drugs will hurt sales of food and drink, billionaire and Ozempic patient Elon Musk took to his social media platform to share his view on medication’s ability to suppress appetite.

有預測稱,新一代減肥藥將影響食品和飲料的銷售,億萬富翁、注射減肥藥Ozempic的伊隆•馬斯克在他的社群媒體平臺上分享了他對藥物抑制食慾能力的看法。

您已閱讀4%(314字),剩餘96%(8143字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×